Evaluation of a protective environment in the management of granulocytopenic patients: A comparative study

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Cancer

• Publication date

  1981-07-15

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/1097-0142(19810715)48:2<419::AID-CNCR2820480234>3.0.CO;2-5PMID 6786730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission.

  1979cited by this paper
• RANDOMIZED TRIAL OF PROTECTED ENVIRONMENT — PROPHYLACTIC ANTIBIOTICS IN 145 ADULTS WITH ACUTE LEUKEMIA

  1978cited by this paper
• Protective environment for marrow transplant recipients: a prospective study.

  1978cited by this paper
• Protected environment--prophylactic antibiotic programmes; clinical studies.

  1976cited by this paper
• Protected environment--prophylactic antibiotic programmes; microbiological studies.

  1976cited by this paper
• Protected environment--prophylactic antibiotic programmes; clinical studies.

  1976cited by this paper
• Letter: Obesity, diet, and type-II hyperlipidaemia.

  1975cited by this paper
• Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

  1975cited by this paper
• Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.

  1974cited by this paper
• Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

  1973cited by this paper
• A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

  1973cited by this paper
• Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

  1973cited by this paper
• Microbiological evaluation of protected environments during patient occupancy.

  1971cited by this paper
• Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia

  1971cited by this paper
• Five-year analysis of protective isolation.

  1971cited by this paper
• Gastrointestinal “sterilization” in the treatment of patients with acute leukemia

  1970cited by this paper
• Studies of patients in a laminar air flow unit

  1969cited by this paper
• Studies of a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results

  1968cited by this paper
• Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Contingency Tables Involving Small Numbers and the χ2 Test

  1934cited by this paper

• Optimizing treatment in paediatric rheumatology—lessons from oncology

  2015cites this paper
• Sensory environment on health-related outcomes of hospital patients.

  2012cites this paper
• How Much Isolation Is Enough for Allografts

  2010cites this paper
• Chapter 10 Prophylaxis

  2009cites this paper
• Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis.

  2009cites this paper
• The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.

  2009cites this paper
• Reverse isolation for neutropenic patients

  2008cites this paper
• Modulation of the host flora

  2005cites this paper
• Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia.

  2005influential citation
• Isolation in the allogeneic transplant environment: how protective is it?

  2005cites this paper
• Neutropenia febril: pasado, presente y futuro

  2005cites this paper
• [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].

  2000cites this paper
• Reflections on gut decontamination in hematology.

  1999cites this paper
• Prevention of infection in children with acute leukaemia

  1996cites this paper
• Prevention of infections in the neutropenic patient.

  1993cites this paper
• Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.

  1993cites this paper
• Critical Appraisal of Antimicrobials for Prevention of Infections in Immunocompromised Hosts

  1993cites this paper
• POPULATION DYNAMICS OF THE INTESTINAL TRACT

  1991cites this paper
• Infection Prevention by Modulation of the Host Flora

  1989cites this paper
• Der Einfluß verschiedener Formen der oralen Dekontamination auf die bakterielle Kolonisation bei Kindern mit Neutropenie

  1988cites this paper
• [Infections and bone marrow autograft carried out for leukemias in children. Apropos of 47 cases].

  1988cites this paper
• Prolonged granulocytopenia due to selective antimicrobial modulation of the intestinal flora of irradiated mice: The impact on recovery from infection

  1988cites this paper
• Stellenwert klinisch angewandter Gnotobiotechnik zur Prophylaxe und während der Therapie granulocytopenischer Infektionen

  1987cites this paper
• [Significance of clinically used gnotobiotechnics in the prophylaxis and during therapy of granulocytopenic infections].

  1987cites this paper
• Prevention of infection in acute leukemia: A prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis

  1986cites this paper
• Antimicrobial prophylaxis in acute leukaemia: Prospective randomized study comparing two methods of selective decontamination

  1983cites this paper